Evolvus Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Evolvus Technologies
The Corporate was formerly known as Blue Skies Technologies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aniket Ausekar, Sharvari Ausekar, Alok Deodhar, and One other member serve as directors at the Company.
- CIN/LLPIN
U72900PN2012PTC142205
- Company No.
142205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Evolvus Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Deodhar  | Director | 22-Sep-2021 | Current |
| Aniket Ausekar | Additional Director | 24-Aug-2015 | Current |
| Sharvari Ausekar | Director | 24-Aug-2015 | Current |
| Anand Mulay | Director | 01-Aug-2022 | Current |
Financial Performance of Evolvus Technologies.
Evolvus Technologies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Evolvus Technologies?
In 2017, Evolvus Technologies had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raygenome Labs Private LimitedActive 8 years 5 monthsAniket Ausekar, Alok Deodhar and 1 more are mutual person
Evolvus Informatics LlpActive 8 years 4 monthsAniket Ausekar and Sharvari Ausekar are mutual person
Evolvus Biotech Private LimitedActive 23 years 28 daysAniket Ausekar and Sharvari Ausekar are mutual person
Personome Medicine Private LimitedActive 20 years 2 monthsAniket Ausekar and Sharvari Ausekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Evolvus Technologies?
Unlock and access historical data on people associated with Evolvus Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evolvus Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evolvus Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
